|
|
Prescription Drugs Market Research
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Prescription Drugs Market, including, but not limited to latest trend on: Prescription Drug; Generic Prescription; Prescription Pharmaceuticals.
We offer market research, industry forecasts, and business analysis in the Prescription Drugs Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
Reports
| Addressing Key Challenges in Drug Safety (Strategic Focus) |
|
| Published : 2008/03 |
| High profile drug withdrawals and negative public attention has placed drug safety at the top of the pharmaceutical industry' s agenda. This report will examine pharmacovigilance technology solutions designed to alleviate the challenges in drug safety man ... |
| Generic League - Market Analysis and Forecasts, 2007-2012, 2017 & 2022 |
|
| Published : 2008/02 |
| This report will provide you with the complete understanding of operations of Top Ten companies that has driven their corporate growth in recent times. In addition, the report sheds significant emphasis on key strategies that will drive year-on-year sales ... |
| Latin American Cardiovascular Drugs Markets |
|
| Published : 2008/01 |
| This research service covers the Latin America Cardiovascular drugs market from 2004 to 2011, with 2006 as the base year. Major markets were studied: Brazil and the Andean Region (which includes Colombia and Venezuela, countries that are estimated to achi ... |
| Abbott Laboratories: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Abbott in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f ... |
| Amgen Inc.: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Amgen in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fo ... |
| Astellas Pharma Inc.: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Astellas in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales ... |
| AstraZeneca plc (incl. MedImmune Inc.): PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for AstraZeneca in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ... |
| Biogen Idec Inc.: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Biogen Idec in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ... |
| Bristol-Myers Squibb Co.: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for BMS in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fore ... |
| Cephalon Inc.: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Cephalon in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales ... |
| Daiichi Sankyo Co., Ltd: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Daiichi Sankyo in the ethical pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f ... |
| Dainippon Sumitomo Pharma Co., Ltd: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Dainippon Sumitomo in the ethical pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal ... |
| Eisai Co., Ltd: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Eisai in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fo ... |
| Eli Lilly & Co.: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Eli Lilly in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sale ... |
| Forest Laboratories Inc.: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Forest in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f ... |
| Gilead Sciences Inc.: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Gilead in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f ... |
| H. Lundbeck A/S: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Lundbeck in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales ... |
| Johnson & Johnson: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for J&J in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fore ... |
| Menarini: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Menarini in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales ... |
| Merck & Co., Inc.: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Merck & Co. in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ... |
| Merck Serono S.A.: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Merck-Serono in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year s ... |
| Mitsubishi Tanabe Pharma Corporation: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Mitsubishi Tanabe in the ethical pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sale ... |
| Pediatric Drugs: the Worldwide Market, 3rd Edition |
|
| Published : 2007/12 |
| Although much of medicine is focused on the increased aging of the population, children still represent the bulk the dependent population worldwide. Important regulatory factors are at work in the pediatric pharmaceutical market. The recognition of the ri ... |
| Pfizer Inc.: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Pfizer in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f ... |
| Sanofi-Aventis: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Sanofi-Aventis in the ethical pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f ... |
| Shionogi & Co., Ltd: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Shionogi in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales ... |
| Shire plc: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Shire in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fo ... |
| Takeda Pharmaceutical Co., Ltd: PharmaVitae Profile |
|
| Published : 2007/12 |
| This analysis examines the historical and forecast performance for Takeda in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f ... |
| U.S. Smoking Cessation Drug Market |
|
| Published : 2007/12 |
| This research service covers the U.S. smoking cessation drug market from 2003-2013. Included are a therapeutic overview, patient forecasts, total market revenue forecasts, product revenue forecasts, and market share analysis. ... |
| Wyeth: PharmaVitae Profile |
|
| Published : 2007/12 |
| This report provides Wyeth PharmaVitae Profile Market Research, Trends, Analysis. ... |
| New Dynamics and Challenges in the Generics Market 2007 |
|
| Published : 2007/11 |
| Generic drugs (generics) are now an established part of pharmaceutical markets and healthcare policies around the world. According to IMS Health data, they already account for 63% of all prescriptions dispensed in the US, the world' s largest single pharm ... |
|
|
View Cart
